Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems are common in thyroid disorders, with dry skin in hypothyroidism and warm, soft skin in hyperthyroidism.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Oral and topical finasteride are effective and safe for treating female hair loss.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

Herbs like aloe vera and amla are effective and safe for treating hair loss.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

High levels of the seizure medication sodium valproate can cause hair loss.

Agomelatine might help stop hair loss caused by valproate.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

Serum ferritin is a better indicator than hemoglobin for detecting low iron in women with chronic hair loss.

Lupus can cause a type of hair loss that doesn't scar, due to inflammation.

The document concludes that most patients with endocrine disorders experience diffuse, non-scarring hair loss, with scarring hair loss being rare.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Telogen effluvium is a common, often temporary hair loss caused by stress and other factors, and it's hard to pinpoint and treat.

Autoimmune diseases like lupus, dermatomyositis, and scleroderma can cause hair loss and other hair problems, and treatments for these diseases might also affect hair.

A man with HIV had hair loss due to syphilis, which improved after penicillin treatment.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.